Trials / Completed
CompletedNCT00267384
N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Soroka University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
This randomized, double-blind, placebo-controlled clinical trial will be performed to assess the effect of N-acetylcysteine therapy on the incidence of nephrotoxicity among patients hospitalized with an infection and treated with aminoglycosides (AGs). Secondary goals of the study will be as follows: comparison of the mortality rates, and length of hospitalization among patients treated with N-acetylcysteine compared to the control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral N-Acetylcysteine |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2008-05-01
- Completion
- 2008-09-01
- First posted
- 2005-12-20
- Last updated
- 2012-06-20
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00267384. Inclusion in this directory is not an endorsement.